Radient Pharmaceuticals Corporation fka RXPC

[The Claw]

$RXPC

http://solutions.standardandpoors.com/NASApp/WS/EntryServlet?pc=IVS&tracking=IVSRADIENT_PHARMACEUTICAL&auth=user&pagename=encrStockReportPDF&company=223134087232255064082233109019029211145204124134

June 12, 2013
On June 4, 2013, Mr. Michael Boswell resigned as a member of Radient
Pharmaceuticals Corporation's Board of Directors. Mr. Boswell's resignation did
not indicate that his resignation was in connection with any disagreement with
the Company pertaining to the Company's operations, policies or practices. Mr.
Boswell resigned to dedicate more of his time to his own business and personal
pursuits. On June 7, 2013, the Board of Directors appointed Mr. Michael
Christiansen to fill the vacancy on Board created by Mr. Boswell's resignation.
Mr. Christiansen was formerly the Executive Vice President and Chief Financial
Officer of Jameson Stanford Resources Corporation and Bolcan Mining
Corporation from May 2012 to November 2012, with his service concluding upon
the closing of the merger of the two companies. Prior to joining Bolcan, Mr.
Christiansen worked at WestPark Capital from 2007 to 2012 as Managing Director
in the Corporate Finance group. Mr. Christiansen has more than fifteen years of
investment banking experience, having served previously with Prudential
Securities from 1997 to 2001, and with Seidler Amdec Securities and Laffer
Associates from 1986 to 1992.